Human CDX2 is known as a caudal-related homeodomain transcription factor that is expressed in the intestinal epithelium and is important in differentiation and maintenance of the intestinal epithelial cells. The caudal-related homeobox proteins bind DNA according to a helix-turn-helix structure, thereby increasing the structural stability of DNA. A cancertumor suppressor role for Cdx2 has been shown by a decrease in the level of the expression of Cdx2 in colorectal cancer, but the mechanism of transcriptional regulation has not been examined at the molecular level. We developed a large-scale system for expression of the recombinant, novel CDX2, in Escherichia coli. A highly purified and soluble CDX2 protein was obtained in E. coli strain BL21(DE3)RIL and a hexahistidine fusion system using Ni-NTA affinity column, anion exchange, and gel filtration chromatographies. The identity and secondary structure of the purified CDX2 protein were confirmed by MALDI-TOF MS, Western blot, and a circular dichroism analyses. In addition, we studied the DNA-binding activity of recombinant CDX2 by ELISA experiment and isolated human CDX2-binding proteins derived from rat cells by an immobilized GST-fusion method. Three CDX2-binding proteins were found in the gastric tissue, and those proteins were identified to the homeobox protein Hox-D8, LIM homeobox protein 6, and SMC1L1 protein.
The caudal-related homeobox proteins bind DNA via an ATrich sequence whose consensus sequence is A/CTTTATA/G. This sequence is found in the promoter of many homeobox genes [16] . Drosophila caudal-related homeobox genes have been found in vertebrates: Cdx1, Cdx2, and Cdx4 in mice, Cdx1 in rat, Cdx3 in hamsters, CHox-cad in chickens, Xcad-1 and Xcad-2 in Xenopus laevis, CDX1, CDX2, and CDX4 in humans [2, [5] [6] [7] [8] [9] . The 180 bp homeobox region encodes a helix-turn-helix DNA-binding motif known as the homeodomain [1] .
CDX1 and CDX2 homeotic genes are activated early during embryonic development in the primordial gut and their expressions are restricted to the intestinal epithelium through adulthood [25] . These two genes are expressed in the epithelium of the small intestine and colon, where they play a crucial role in the regulation of cell proliferation and differentiation [3, 13, 18, 20] . Oncogenic ras downregulates Cdx2, but upregulates Cdx1 expression in human colon carcinoma Caco-2 and HT-29 cells [15] .
Cdx2 encodes a nuclear transcriptional factor that is expressed in the differentiated enterocytes and binds ciselements presented in the gene promoters of enterocytic markers such as sucrase-isomaltase (SI), lactase-phlorizin hydrolase (LPH), apolipoprotein B, carbonic anhydrase 1, and calbindin D9K [10, 12, 14] . Cdx2 deficiency is responsible for the failure of clones to generate functional blastocysts and exclude other genetic alterations acquired during in vitro manipulation of the cells in the characteristic block to implantation [26] . A cancer-tumor suppressor role for Cdx2 has been shown by a decrease in the level of the expression of Cdx2 in colorectal cancer and by the genetic alteration of Cdx2 during colon carcinogenesis [17, 28] .
CDX2 expression has been evaluated with respect to the SNPs and histopathologic characteristics of the tumors. CDX2 expression levels have been strongly associated with microsatellite instability and tumor location in the gastrointestinal tract, consistent with a possible role in the specification of gastrointestinal epithelial cell fate in humans [24] . However, the structural basis and molecular mechanism of CDX2 homeoprotein as a tumor suppressor in intestinal cancer is still unknown. In order to obtain pure and soluble proteins for structural study, we subcloned, overepressed, and purified a truncated form of novel CDX2 protein containing the N-terminal caudal-like activation region and the C-terminal homeobox domain. Furthermore, we performed ELISA experiments to study the DNAbinding activity of CDX2 and isolated CDX2-binding proteins derived from rat cells by an immobilized GSTfusion method.
MATERIALS AND METHODS

Cloning of CDX2
Sequences of CDX2 corresponding to amino acids 13-248 of fulllength CDX2 (1-313) were amplified by PCR with oligonucleotides incorporating the NdeI and the XhoI sites on the 5' primer and 3' primer containing a stop codon. CDX2 (13-248):
A PCR reaction was sustained for 30 cycles, with denaturing at 94 o C for 1 min, annealing at 57 o C for 1 min, and extension at 72 o C for 1 min. After digestion of the CDX2 fragment, it was incorporated into the plasmid pET-15b with strong T7 transcriptional and translational sequences. The positive His 6 -CDX2 expression plasmid was identified by restriction endonuclease digestion and further verified by DNA sequencing on a Macrogen automatic DNA sequencer.
Media and Expression Conditions
The recombinant plasmid pET-15b-CDX2 (13-248) was transformed into competent E. coli strain BL21(DE3)RIL. A single colony was inoculated with 200 ml of LB (Luria-Bertani) medium containing 50 µg/ml ampicillin and 170 µg/ml chloramphenicol. Bacteria were grown at 37 o C overnight. The resultant cultures were added to 4 l of fresh LB medium containing ampicillin and chloramphenicol, and incubated with agitation at 37 o C until the OD 
Purification of the Recombinant Protein
The cleared supernatant from the protein extraction step was loaded onto an Ni-NTA (Amersham-Pharmacia Biotech) column and preequilibrated with buffer A. The column was washed with buffer A containing imidazole and elution of the bound protein was achieved by varying the amounts of imidazole from 20 to 200 mM. Protein elution was monitored at 280 nm and the resulting fractions were analyzed by electrophoresis on 12% SDS-PAGE gel. The eluted protein solution from the previous step was applied to a column of Q-Sepharose fast flow (Amersham-Pharmacia Biotech) and washed extensively with buffer B (50 mM Tris-HCl, pH 7.5, and 350 mM NaCl). Elution of the bound protein from this column was achieved by varying the amount of salt in the 50 mM Tris-HCl buffer. Proper fractions were pooled and concentrated by ultrafiltration (Vivaspin) and applied to a Superdex 75 column equilibrated with a buffer from 200 mM to 1 M NaCl. Preparative chromatography was performed on the HPLC system.
Protein Analysis and Concentration Determination
To establish the level of expression and the purity of the protein, an SDS-PAGE using 12% polyacrylamide gel was performed. Following electrophoresis, the protein was stained with Coomassie brilliant blue R-250 in 50% methanol and 10% acetic acid. The protein concentration was determined by a BioPhotometer using a UVette of 10-mm optical pathlength and measured using the Bradford method with the Bio-Rad protein assay kit, utilizing bovine serum albumin as a standard.
Western Blotting
The purified CDX2 protein from the SDS-PAGE (12%) was transferred onto a nitrocellulose membrane at 115 V for 1 h. The membrane was blocked with 5% skim milk in Tween-PBS buffer containing 1% Tween 20 for 2 h. The membrane was then incubated in the primary antibody (mouse monoclonal antibody [Abcam Inc.] diluted 1:1,000) for 12 h. After washing with Tween-PBS, the membrane was incubated for 80 min with the secondary antibody, which was anti-mouse horseradish peroxidase (HRP) IgG (Abcam Inc.) diluted at a ratio of 1:2,000 in blocking buffer.
MALDI-TOF MS Analysis
MALDI-TOF MS was used to determine the molecular mass of the purified protein. The N-terminally his-tagged CDX2 (13-248) fusion protein was found to have a molecular mass of 27 kDa. A peptide mass-fingerprinting analysis was carried out by subjecting the protein to trypsin digestion. The sequences of the digested peptides were matched with the protein sequences in the database using Mascot software [21] . This analysis identified the recombinant protein as his-tagged derivatives of the CDX2 protein.
Circular Dichroism Measurement
A circular dichroism measurement was carried out with a spectropolarimeter (JASCO J-715) using a 0.1-cm cell at 0.2-nm intervals at 25 o C. The CD spectrum of the purified recombinant CDX2 protein (the average of five scans) was recorded in the 200-260 nm range. A far-UV CD spectrum was taken at the protein concentration of 0.5 mg/ml. The CD spectrum was obtained in millidegrees and converted to molar ellipticity prior to secondary structure analysis. Calculation of the content of the protein's secondary structure elements was performed using the CDNN program.
Enzyme-Linked Immunoassay (ELISA) Double-stranded DNAs (5'-ATATAAAATG-3', 3'-TATATTTTAC-5') and biotin-labeled DNAs were purchased from Biosolution and Genotech, respectively. Multiwell plates were coated overnight at 37 o C with streptavidin (5 µg/well), and washed with 1× PBS. The plate was blocked for 2 h in 0.3% bovine serum albumin (BSA) in PBS, 200 µl/well at room temperature, and rinsed with PBST (1×) and PBS (3×) containing 0.1% BSA. The plate was then ready for further use. Serial dilutions of purified CDX2 and CDX1 proteins were incubated in binding buffer (5 mM Tris, 0.5 mM EDTA, 50 mM KCl, pH 7.8.) with monoclonal antibody (MAb) of CDX2 and CDX1 (1 µg) for 10 min at 20 o C, and then biotin-labeled DNAs (500 ng) were added and mixed. Then, 50 µl of MAb/CDX2/CDX1 DNA sample was added to streptavidin-coated plates and incubated for 30 min at 4 o C. The samples were drained and rinsed with PBST and PBS containing 0.1% BSA, and then 50 µg of anti-mouse IgG peroxidase-conjugated antibody (1:1,000 dilution) in PBS containing , 0.1 mM phenylmethylsulfonyl fluoride, 5 µg/ml aprotinin, and 1 µM pepstatin); unbroken cells were removed by centrifugation at 1,000 ×g for 10 min followed by centrifugation at 100,000 ×g for 40 min. The pellets were treated with buffer A containing 1% Triton X-100 to solubilize membraneassociated proteins and centrifuged at 100,000 ×g for 40 min to remove insoluble pellets. Immobilized GST fusion proteins were reacted with aliquots (5 mg) of the membrane extracts and washed three times with buffer A containing 0.1% Triton X-100 prior to SDS electrophoresis. After staining with Coomassie Brilliant Blue, the candidate band was excised from the gel and digested with trypsin. The masses of the tryptic peptides were measured with a Voyager DE time-of-flight mass spectrometer (Perspective Biosystems, Inc., Framingham, MA, U.S.A.) at Pohang University of Science and Technology. Matrix-assisted laser desorption/ionization was performed with α-cyano-4-hydroxycinnamic acid as the matrix. Comparison of the mass values against the Swiss-Prot database was performed using Peptide Search [11] .
Electrophoretic Mobility Shift Assay (EMSA) Binding reactions of different protein. DNA molar ratios were assembled at 298 K in a total volume of 10 µl in 10 mM Tris-Hd pH 7.5, 50 mM NaCl, 1 mM MgCl 2 , 0.5 mM DTT, 0.5 mM EDTA, 100 µg/ml BSA, 10 µg/ml poly (dI-dC), and 4% (v/v) glycerol. Purified CDX2, incubated in the binding buffer at 298 K for 10 min prior to the addition of oligo-DNA, was identical to that used in interaction. Reaction mixtures were loaded onto a 6% nondenaturing polyacrylamide gel that had been pre-run at 277 K for 30 min in 0.5× TBE (45 mM Tris, 45 mM borate, 1 mM EDTA, pH 8.3). Electrophoresis continued for about 1 h before the gel was stained with Coomassie blue in 0.5× TBE buffer.
RESULTS AND DISCUSSION
Full-length CDX2 protein contains two domains. It is known that the N-terminal caudal-like activation region (amino acids 13-180) mediates transcription activation, and that the C-terminal homeobox domain (amino acids 184-248) binds DNA according to a helix-turn-helix (HTH) structure [1] . A fragment of human CDX2 (amino acids 13-248) containing both caudal-like activation and HTH regions was successfully constructed and purified. Most studies have indicated tumor suppressor functions of Cdx2, which inhibits proliferation, whereas the effects of Cdx1 are controversial [14] . The domains and the sequence alignments of full-length CDX1 and CDX2 are shown in Fig. 1 . CDX1 and CDX2 display a 55% sequence identity (Fig. 1B) . The C-terminal homeobox domains are highly conserved in CDX1 and CDX2 proteins, whereas the Nterminal caudal-like activation regions show a very low degree of sequence identity. CDX1 and CDX2 are structurally related proteins that are highly expressed in the epithelium of the small intestine and colon.
Murine Cdx2 is known to reduce cell growth in IEC, Caco-2, and HT29 cells, but the effect has not been examined at the molecular level [23] . Until now, there have been no reports of CDX2 structures. We developed a large-scale system for expression of the recombinant, novel CDX2, for further structural and functional studies in the Escherichia coli cell. A PCR-amplified CDX2 gene was inserted into the expression vectors pET-15b and pGEX-4T-1 in order to express His 6 -tagged and GST fusion proteins, respectively. The sequences of the inserts were confirmed by DNA sequencing. The GST-CDX2 (full-length) fusion protein (59 kDa) and His 6 fusion protein (35 kDa) were expressed in BL21(DE3)RIL. Full-length CDX2 was expressed at high levels in the GST and pET systems, but most of the CDX2 proteins were insoluble in E. coli BL21(DE3)RIL in the small-scale and large-scale expression systems.
To determine the soluble and overexpressed regions, the clonings of 3 fragments were conducted as follows. CDX2 (13- In the case of CDX2 (13-180), although it was expressed at a high level in the pET system, the protein of the fraction was insoluble. Conversely, when CDX2 (13-180) was expressed in the GST vector, there was a high improvement in the solubility. In the case of CDX2 (48-311), its expression in the GST vector was performed. The soluble GST-CDX2 (48-311) fusion protein (54 kDa) was overexpressed in BL21(DE3)RIL. However, neither protein (13-180 or 48-311) was highly purified in the GST vectors.
In the case of CDX2 (13-248), the lysate supernatant and lysate pellet by Coomassie blue staining of the SDS-PAGE separation were shown after induction as a band corresponding to the predicted molecular mass of 27 kDa (Fig. 2) . For overexpression of CDX2 (13-248), E. coli BL21(DE3)RIL as bacterial hosts and pET15b vector were chosen. CDX2 (13-248) was expressed at high levels in the pET system, and most of the CDX2 proteins were soluble in E. coli BL21(DE3)RIL. The CDX2 protein was purified from an Ni-NTA column with an affinity to the fusion partner, the His-tag (Fig. 2) . The column loading the CDX2 protein was washed with buffer A containing 20 and 50 mM imidazole. The optimum elution for the purification was found in the 100 mM imidazole concentration. The fraction eluted from 100 mM imidazole was loaded onto a prepacked column of Q-Sepharose-based strong anion exchange, and then eluted with a gradient of the 350 mM NaCl solution. After affinity chromatography and ion-exchange chromatography, the protein was purified further by using a Superdex-75 column. Whereas the purified fraction of the CDX2 protein was shown as a band in a peak, there were nonspecific contaminants in the other peaks. The contaminants were eliminated by a final Superdex-75 column, successfully purifying the CDX2 protein to a high degree. The resulting volumes and purities of the protein at each step of purification are shown in Table 1 . The protein was concentrated in a soluble form to a final concentration of 4 mg/ml, as determined using a quantification kit with bovine serum (Fig. 3A) .
To compare the expression efficiencies, four types of E. coli strains [DH5α, BL21(DE3), BL21(DE3)RIL, and XLBlue] and two fusion systems with glutathione S-transferase and hexahistidine were used. Fusion proteins with different tags were expressed in the two fusion systems but their levels of expression varied. The expression rate and fusion protein solubility of the His 6 fusion system in the BL21(DE3)RIL were higher than those in the CDX2 protein.
The circular dichroism spectrum of the CDX2 (13-248) showed the dominance of the α-helix structure, exhibiting two negative bands at about 210 nm and 220 nm (Fig. 4A) . The CD signal was converted to mean residue ellipticity (MRE) using the equation MRE=θ/ (10· l·C·N A ) , where θ is the ellipticity in mdeg, l is the light pathlength in cm, C is the molar concentration of the protein, and N A is the number of CDX2 residues. Deconvolution of the spectrum using the CDNN program indicated the following secondary structure contents: 67.8% α-helices, 6.8% β-sheets, 16.2% turns, and 9.2% non-ordered form. MALDI-TOF MS studies revealed the approximate molecular mass of the recombinant protein, which was in accordance with the theoretical mass prediction for the CDX2 protein with the peptide mass tolerance (50 ppm) (Fig. 4B) . A mass-fingerprinting analysis of the proteins was carried out by subjecting them to trypsin digestion. The monoisotopic masses obtained for the individual peptides were in the range of 800-3,000 Da. The sequences of the digested peptides were matched with the protein sequences in the database using the Mascot program. The expression of the CDX2 protein was confirmed by Western blot analysis (Fig. 3A) . All of the bands of the analysis showed similar intensities at various concentrations.
One fragment (13-248) of CDX2 was identified as a soluble region by SDS-PAGE, MALDI-TOF MS, and Western blot analyses. This region was successfully highpurified and was predicted to be composed of α-helices, β-sheets, and turns by circular dichroism. The identification and purification of this soluble region will facilitate structural studies aimed at understanding the protein functions that occur within the domains. CDX2 is relatively rich in proline residues. The proline residue region (amino acids 257-298) induces an obstacle in an α-helix or β-sheet that causes aggregation. In the present study, CDX2 (48-311) containing the proline residue region was first purified (Fig. 3B) . A Western blot analysis indicated that the purified protein consisted of two positive bands, which were divided by proline-rich residues (Fig. 3B) . Moreover, purified GST-CDX2 (13-180), a caudal-like activation region, cleaved itself several times (Fig. 3C ). However, the purified GST-CDX2 was not cleaved by thrombin, which might be explained by the coverage of the thrombin cleavage site. The CDX2 (13-248) recombinant construct was, for the first time, successfully isolated in a soluble and highly purified form. The homeobox domain (184-248) binds DNA according to a helix-turn-helix (HTH) structure, thereby increasing the structural stability of the DNA. To determine the binding potency of the CDX2 and CDX1 proteins on biotinylated DNAs, we performed ELISA experiments. The experiment was carried out by increasing the amount of CDX2 and CDX1 proteins with a fixed amount of oligonucleotide coated on the plate. Fig. 5 indicates that the DNA-protein complex at low concentration ratio (1:1) was found to have a high OD value, whereas the values decreased in DNA protein complexes at higher concentration ratios (1:2, 1:5, and 1:10). By this assay, we observed that CDX2 and CDX1 binding to its target DNA can be saturated at 1:1 DNA-protein ratio, and the binding between this complex is found to be efficient. The fragment including the homeobox domain might be due to enhanced thermal stability of proteins. The CDX2 (13-248) fragment increases structural stability, decreases the exposure of the hydrophobic patch, and induces resistance to trypsin cleavage. The results achieved in the present study might apply to the purification of CDX1, CDX3, and CDX4 in humans and other proteins including the homeobox-domain-related proteins. The homeobox domains are highly conserved in eukaryotic organisms. The functions of CDX1 and CDX2 are different in that they involve not the homeobox-domain region but the Nterminal caudal-like activation region (amino acids 13-180). These results indicate that conformational changes occur in that region , which might cause differences of function between CDX1 and CDX2. To further investigate the protein-protein interactions of CDX2, we isolated CDX2 in human binding proteins derived from rat cells (the gastric tissue and the small intestine) by an immobilized GST-fusion method (Fig. 6) . Three CDX2-binding proteins were found in the gastric tissue, and those proteins were identified as homeobox protein Hox-D8, LIM homeobox protein 6, and SMC1L1 protein. However, we could not find them in the small instestine. The LIM-homeobox gene regulates the development of cholinergic neurons in the spinal cord [22] and is expressed in telencephalic cholinergic neurons at late embryonic stages [27] . The Hox genes are a large family of DNA-binding transcription factors that play a crucial role in defining body patterning of metazoans. SMC1 seems to have multiple roles that differ from those of the other cohesion complex factors: besides having a structural function, it is involved in genome stability [19] , DNA repair and recombination, and gene expression [4] . The presence of a homeodomain-binding site cannot alone explain the cell-specific function of the promoter, because other cell types contain homeodomain proteins that bind the same site. Here, we demonstrated that CDX2 directly binds the homeobox protein Hox-D8, LIM-homeobox protein 6, and SMC1L1 protein. These results provide valuable information on the development of CDX2 expression for structural study, binding activity of the CDX2 protein to DNA, and protein-protein interaction of caudal-related homeodomain transcription factor. To confirm the DNA-binding activity of the recombinant CDX2, we performed an EMSA experiment and the result is shown in Fig. 7 , in which the correct 1:1 stoichiometry of CDX2:dsDNA was also confirmed. 
